Answers are grounded in this paper and cite their sources.
= .01) were independent risk factors for discontinuing ibrutinib due to transformation. Our results suggest that near-tetraploidy is a potential prognostic marker for Richter transformation to assess in patients going on ibrutinib.
No takes yet. Share an insight, caveat, or question.
Miller et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: